EP 3962359 A4 20230125 - METHODS FOR ESTIMATING KEY PHENOTYPIC TRAITS FOR OBSTRUCTIVE SLEEP APNEA AND SIMPLIFIED CLINICAL TOOLS TO DIRECT TARGETED THERAPY
Title (en)
METHODS FOR ESTIMATING KEY PHENOTYPIC TRAITS FOR OBSTRUCTIVE SLEEP APNEA AND SIMPLIFIED CLINICAL TOOLS TO DIRECT TARGETED THERAPY
Title (de)
VERFAHREN ZUR SCHÄTZUNG WICHTIGER PHÄNOTYPISCHER MERKMALE FÜR OBSTRUKTIVE SCHLAFAPNOE UND VEREINFACHTE KLINISCHE WERKZEUGE ZUR GEZIELTEN THERAPIE
Title (fr)
PROCÉDÉS D'ESTIMATION DE TRAITS PHÉNOTYPIQUES CLÉS POUR L'APNÉE OBSTRUCTIVE DU SOMMEIL ET OUTILS CLINIQUES SIMPLIFIÉS POUR DIRIGER UNE THÉRAPIE CIBLÉE
Publication
Application
Priority
- AU 2019901736 A 20190522
- AU 2020050506 W 20200522
Abstract (en)
[origin: WO2020232509A1] A method of predicting the likelihood of responding to one or more obstructive sleep apnea (OSA) treatments for obstructive sleep apnea (OSA) of a candidate subject, the method including the steps of: (a) measuring a first series of polysomnography and anthropometric parameters for at least a collection of OSA sufferers; (b) correlating the parameters with at least one of the corresponding upper-airway collapsibility (Pcrit), arousal threshold, loop gain and pharyngeal muscle responsiveness measurement of each subject; (c) determining a corresponding description structure describing the correlation of step (d); and (d) utilising the corresponding description structure, in conjunction with a series of polysomnography and anthropometric parameters measured for the candidate subject to predict the likelihood of responding to one or more obstructive sleep apnea (OSA) treatments to thereby provide a clinical decision diagnostic tool for obstructive sleep apnea.
IPC 8 full level
A61B 5/08 (2006.01)
CPC (source: AU EP US)
A61B 5/0826 (2013.01 - AU EP US); A61B 5/0871 (2013.01 - US); A61B 5/107 (2013.01 - AU US); A61B 5/14551 (2013.01 - AU US); A61B 5/4809 (2013.01 - AU US); A61B 5/4812 (2013.01 - AU US); A61B 5/4815 (2013.01 - AU US); A61B 5/4818 (2013.01 - AU EP US); A61B 5/4872 (2013.01 - AU US); A61B 5/7264 (2013.01 - AU EP US); A61B 5/7275 (2013.01 - AU US); A61F 5/566 (2013.01 - US); G06N 3/02 (2013.01 - US); G06N 5/01 (2023.01 - EP US); G06N 7/01 (2023.01 - US); G06N 20/00 (2018.12 - EP US); G16H 20/40 (2017.12 - EP US); G16H 50/20 (2017.12 - AU EP US); A61B 5/0871 (2013.01 - AU); A61F 5/566 (2013.01 - AU); G06N 3/02 (2013.01 - AU); G06N 7/01 (2023.01 - EP); G06N 20/00 (2018.12 - AU)
Citation (search report)
- [XI] US 2007239056 A1 20071011 - MOORE KENT [US]
- [A] ZINCHUK ANDREY V ET AL: "Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches", SLEEP MEDICINE REVIEWS, vol. 35, 12 October 2016 (2016-10-12), pages 113 - 123, XP085168940, ISSN: 1087-0792, DOI: 10.1016/J.SMRV.2016.10.002
- [A] VAVOUGIOS GEORGE D. ET AL: "Phenotypes of comorbidity in OSAS patients: combining categorical principal component analysis with cluster analysis", JOURNAL OF SLEEP RESEARCH, vol. 25, no. 1, 1 February 2016 (2016-02-01), GB, pages 31 - 38, XP093008266, ISSN: 0962-1105, Retrieved from the Internet <URL:https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjsr.12344> DOI: 10.1111/jsr.12344
- [A] ECKERT DANNY J: "Phenotypic approaches to obstructive sleep apnoea - New pathways for targeted therapy", SLEEP MEDICINE REVIEWS, vol. 37, 18 December 2016 (2016-12-18), pages 45 - 59, XP085319073, ISSN: 1087-0792, DOI: 10.1016/J.SMRV.2016.12.003
- See references of WO 2020232509A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2020232509 A1 20201126; AU 2020278409 A1 20211202; EP 3962359 A1 20220309; EP 3962359 A4 20230125; US 2022218274 A1 20220714
DOCDB simple family (application)
AU 2020050506 W 20200522; AU 2020278409 A 20200522; EP 20809887 A 20200522; US 202017613041 A 20200522